Julie Winkler, the Chief Commercial Officer of CME Group, recently sold 10,079 shares of the company's Class A common stock on November 2, 2026. This transaction is significant as it reflects ongoing executive activity within the company, which is a major player in the security and commodity brokers industry.

Winkler's sale was executed at a weighted average price of $305.15 per share, with individual transaction prices ranging from $305.11 to $305.34. Following this sale, she retains ownership of 21,482 shares. The filing indicates that Winkler is not a director or a ten percent owner but holds an officer position within the company.

Background

CME Group Inc., based in Chicago, is a leading global marketplace for derivatives and futures trading. The company is classified under the SIC code for security and commodity brokers, dealers, exchanges, and services. CME Group operates various exchanges and offers a wide range of financial products, including options and futures across different asset classes.

The recent filing, with accession number 0001692514-26-000005, is part of a series of reports submitted by Winkler, reflecting her ongoing transactions in CME Group's stock. This filing is one of several recent submissions, including another Form 4 filed on the same day and a Form 144 regarding the sale of shares.

What the Filing Says

The SEC filing notes, "These shares were sold in multiple transactions at prices ranging from $305.11 to $305.34, inclusive." This detail indicates that Winkler's sale was executed through various trades, which is common for large stock transactions to minimize market impact.

Impact

The sale of shares by Winkler may affect investor perceptions of CME Group, particularly regarding executive confidence in the company's future performance. While such transactions are not uncommon, they can lead to speculation about the company's direction and the motivations behind insider sales.

What's Next

The filing does not specify what happens next regarding Winkler's stock transactions or any upcoming corporate actions. Investors and analysts will likely continue to monitor insider transactions for insights into executive sentiment and company performance.